TIP_link_300x300.jpg
Solvent Evaporation Market to Outstrip $821.41 Million by 2028 Growing Sturdy at 6.7% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 22, 2021 13:25 ET | The Insight Partners
Pune, India, June 22, 2021 (GLOBE NEWSWIRE) -- Solvent Evaporation Market: Key InsightsAccording to our new research study on “Solvent Evaporation Market to 2028 – Global Analysis and Forecast – by...
PAOG New Logo.jpg
PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd
June 21, 2021 10:35 ET | PAO Group, Inc.
Sandusky, Ohio, June 21, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceuticals Business Development Update scheduled for release this week, on Wednesday,...
Syneos Health_rgb_r.jpg
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors
June 21, 2021 08:05 ET | Syneos Health, Inc.
MORRISVILLE, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today expanded its Decentralized Clinical Trial...
PAOG New Logo.jpg
PAOG CBD Nutraceuticals Rollout On Track Targeting $5 Billon Market
June 17, 2021 10:50 ET | PAO Group, Inc.
Sandusky, Ohio, June 17, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the company’s plan to launch a CBD Nutraceuticals line of products expected to generate revenue...
Syneos Health_rgb_r.jpg
Dr. David S. Wilkes Appointed to Syneos Health Board of Directors
June 16, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of David S....
Beroni Logo @ Dec 2019.png
Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
May 28, 2021 08:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
Beroni Logo @ Dec 2019.png
Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans
May 28, 2021 08:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
logo.jpg
Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 09:15 ET | Vallon Pharmaceuticals Inc.
- Company remains on track to report pivotal data from lead program, ADAIR, in second half 2021 - Novel abuse-deterrent platform technology enables pipeline expansion opportunities across multiple...
Cellectis Logo.png
Monthly information on share capital and company voting rights
May 10, 2021 16:30 ET | Cellectis Inc.
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Syneos Health_rgb_r.jpg
Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA
May 06, 2021 07:30 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior...